Twenty years of progress in type 1 diabetes mellitus
Crossref DOI link: https://doi.org/10.1038/s41574-025-01177-x
Published Online: 2025-09-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kay, Thomas W. H.
Couper, Jennifer J.
Text and Data Mining valid from 2025-09-11
Version of Record valid from 2025-09-11
Article History
First Online: 11 September 2025
Competing interests
: T.K. has consulted for Eli Lilly, Sanofi and SAB Biotherapeutics. J.J.C. has consulted for Sanofi.